Search Market Research Report
Embolization Particles Market Size, Share Global Analysis Report, 2022 – 2028
Embolization Particles Market By Product (Radioembolization Spheres, Microspheres, Drug Eluting Beads, Others), By Application (Peripheral Vascular Disease, Neurology, Oncology, Urology, Others), By End-user (Hospitals, Ambulatory Centers, Clinics), and By Region - Global Industry Insights, Growth, Size, Share, Comparative Analysis, Trends, Statistical Research, Market Intelligence, and Forecast 2022 – 2028
Industry Insights
[201+ Pages Report] According to Facts and Factors, the global embolization particles market size was valued at USD 1,329.5 million in 2021 and is predicted to increase at a CAGR of 11.30% to USD 2,527.3 million by 2028. The study examines the market in terms of revenue in each of the major regions, which are classified into countries.
Market Overview
Embolization is a minimally invasive surgery that limits blood supply to a specific location of the body, causing an aneurysm or tumor to constrict effectively. This procedure is also used to treat carcinogenic tumours, haemorrhages, and control malignant hypertension caused by renal failure. Various interventional radiology procedures use embolization. An interventional radiologist utilizes imaging guidance to implant the catheter into a primary artery and moves it to a channel leading to a tumour or another area where blood flow must be restricted. Embolization is a treatment option for some people who have tumours that cannot be surgically removed. It can be used to treat tumours that are greater than 5 cm in diameter and are resistant to ablation.
One of the major factors driving the growth and demand of the embolization particle market is the fast rise in cancer prevalence in the region. In addition, the growing use of embolization as a treatment for illnesses other than cancer, such as vascular malformations and fibrosis, is expected to contribute to the global market's growth from 2021 to 2028. The market's growth is further aided by the vast expansion of the healthcare domain and the increasing focus of research institutes on modernizing technology for new and enhanced diagnosis and treatment methods.
Impact of COVID - 19
COVID 19 has impacted 215 countries, as well as the market for embolization particles. Countries have implemented lockdowns to combat the harmful impacts, which have had a negative impact on the embolization particle business. The epidemic poses a number of issues for the industry, as it affects people all around the world. Many factors have influenced continuous demand and supply, including the possibility of manufacturing interruptions, supply chain disruptions, distribution issues, a shortage of workforce employees, and considerably reduced development activities. People aren't as active as they used to be. There are major strategic shifts taking place. Because of the rising demand from customers all throughout the world, multinational corporations are boosting their investments in the embolization particle industry.
The complete research study looks at both the qualitative and quantitative aspects of the embolization particles market. Both the demand and supply sides of the market have been investigated. The demand side study examines market income in various regions before comparing it to all of the major countries. The supply side research examines the industry's top rivals, as well as their regional and global presence and strategies. Each major country in North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America is thoroughly investigated.
Segmentation Analysis
The global embolization particles market is segregated based on product, application, end-user and region.
The market for embolization particles is divided into four categories: product type, application, end-user, and region. The market is divided into radioembolization spheres, microspheres, drug eluting beads, PVA particles and Gel foam particles, and other particles based on product type segmentation. The market is divided into peripheral vascular disease, neurology, cancer, urology, and other applications. The market is divided into three types of end-users: hospitals, ambulatory centers, and clinics.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 1,329.5 Million |
Projected Market Size in 2028 |
USD 2,527.3 Million |
CAGR Growth Rate |
11.30% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
Abbott Laboratories, Boston Scientific Corporation, BTG plc, Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Pfizer, Inc., Sirtex Medical Limited, St. Jude Medical, Inc., Terumo Corporation, and Others |
Key Segment |
By Product Type, Application, End-User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Regional Landscape
The geographical study of several embolization particle marketplaces, such as Asia Pacific, North America, European nations, and the rest of the globe countries, is being divided and analyzed. According to Geographical, North America is expected to be the largest market in terms of profit contribution owing to the rising adoption of cloud-based services by production systems and distribution channels. Furthermore, due to increased investment, Asia Pacific countries are expected to develop rapidly in the market. In addition, demand has increased in key developing countries. For example, in various Asia-Pacific areas, India and China are expected to drive the increase in embolization particle demand.
Key Players Insights
The report contains qualitative and quantitative research on the global embolization particles Market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness.
List of Key Players in the Global Embolization Particles Market:
- Abbott Laboratories
- Boston Scientific Corporation
- BTG plc
- Cook Medical, Inc.
- Edwards Lifesciences
- Johnson & Johnson
- Pfizer, Inc.
- Sirtex Medical Limited
- St. Jude Medical, Inc.
- Terumo Corporation
The Global Embolization Particles Market is segmented as follows:
By Product
- Radioembolization Spheres
- Microspheres
- Drug Eluting Beads
- Others
By Application
- Peripheral Vascular Disease
- Neurology
- Oncology
- Urology
- Others
By End-user
- Hospitals
- Ambulatory Centers
- Clinics
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Content
Industry Major Market Players
- Abbott Laboratories
- Boston Scientific Corporation
- BTG plc
- Cook Medical Inc.
- Edwards Lifesciences
- Johnson & Johnson
- Pfizer Inc.
- Sirtex Medical Limited
- St. Jude Medical Inc.
- Terumo Corporation
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors